Joseph W La Plume Charles River Laboratories International, Inc. (CRL) insider trading activity

Joseph W La Plume is EVP, Corp Strategy & Develop of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Currently has a direct ownership of 25,316 shares of CRL, which is worth approximately $3.82 Million. The most recent transaction as insider was on Jun 05, 2025, when has been sold 385 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.3K

26.5% 3M change

4.18% 12M change

Total Value Held $3.82 Million

Joseph W LaPlume Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 05 2025	SELL Bona fide gift	-	385 Reduced 1.5%	25,316 Common Stock
May 31 2025	SELL Payment of exercise price or tax liability	$21,022 $135.63 p/Share	155 Reduced 0.6%	25,701 Common Stock
May 30 2025	BUY Grant, award, or other acquisition	$909,941 $135.63 p/Share	6,709 Added 20.6%	25,856 Common Stock
May 28 2025	SELL Payment of exercise price or tax liability	$11,507 $138.65 p/Share	83 Reduced 0.43%	19,147 Common Stock
May 27 2025	SELL Payment of exercise price or tax liability	$16,681 $136.73 p/Share	122 Reduced 0.63%	19,230 Common Stock
May 26 2025	SELL Payment of exercise price or tax liability	$22,013 $136.73 p/Share	161 Reduced 0.83%	19,352 Common Stock
May 13 2025	SELL Open market or private sale	$72,705 $145.41 p/Share	500 Reduced 2.5%	19,513 Common Stock
Feb 20 2025	SELL Open market or private sale	$715,000 $162.5 p/Share	4,400 Reduced 18.02%	20,013 Common Stock
Jan 31 2025	SELL Payment of exercise price or tax liability	$140,072 $165.57 p/Share	846 Reduced 3.35%	24,413 Common Stock
Jan 31 2025	BUY Grant, award, or other acquisition	-	2,738 Added 9.78%	25,259 Common Stock
Aug 08 2024	SELL Open market or private sale	$354,860 $199.36 p/Share	1,780 Reduced 7.32%	22,521 Common Stock
Jun 03 2024	SELL Bona fide gift	-	311 Reduced 1.26%	24,301 Common Stock
May 31 2024	BUY Grant, award, or other acquisition	-	2,111 Added 7.9%	24,612 Common Stock
May 29 2024	SELL Payment of exercise price or tax liability	$47,835 $214.51 p/Share	223 Reduced 0.98%	22,501 Common Stock
May 28 2024	SELL Payment of exercise price or tax liability	$27,151 $217.21 p/Share	125 Reduced 0.55%	22,724 Common Stock
May 27 2024	SELL Payment of exercise price or tax liability	$39,966 $217.21 p/Share	184 Reduced 0.8%	22,849 Common Stock
May 26 2024	SELL Payment of exercise price or tax liability	$52,782 $217.21 p/Share	243 Reduced 1.04%	23,033 Common Stock
May 10 2024	SELL Open market or private sale	$295,968 $226.97 p/Share	1,304 Reduced 5.31%	23,276 Common Stock
Feb 15 2024	SELL Open market or private sale	$200,223 $238.93 p/Share	838 Reduced 3.29%	24,620 Common Stock
Jan 29 2024	SELL Payment of exercise price or tax liability	$225,787 $220.28 p/Share	1,025 Reduced 3.87%	25,458 Common Stock
Jan 29 2024	BUY Grant, award, or other acquisition	-	3,350 Added 11.23%	26,483 Common Stock
Nov 30 2023	SELL Open market or private sale	$365,800 $197.73 p/Share	1,850 Reduced 7.41%	23,133 Common Stock
Nov 09 2023	SELL Open market or private sale	$1,581,517 $173.26 p/Share	9,128 Reduced 26.76%	24,983 Common Stock
Nov 09 2023	BUY Exercise of conversion of derivative security	$1,320,547 $144.67 p/Share	9,128 Added 21.11%	34,111 Common Stock
Aug 10 2023	SELL Open market or private sale	$151,564 $216.52 p/Share	700 Reduced 2.73%	24,983 Common Stock

JWL

Joseph W La Plume

EVP, Corp Strategy & Develop

Wilmington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRL shares.

Notify only if

Value

Insider Trading

Get notified when an Charles River Laboratories International, Inc. insider buys or sells CRL shares.

Notify only if

Operation

Value

Type

News

Receive news related to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Track Activities on CRL

Account